(Fig. 5) As m6A-modified LINC00958 plays an essential role in HCC progress, XL Zu et al. developed a novel PLGA-based nanoplatform encapsulating si-LINC00958 for HCC systemic administration. This evidence concerns the gene LINC00958 and hepatocellular carcinoma.